Systemic inflammation has been suggested to have a pivotal role in atherothrombosis, but
the factors that trigger systemic inflammation have not been fully elucidated …

Hospitalised patients with decompensated cirrhosis are in a rebalanced haemostatic state
due to a parallel decline in both pro-and anti-haemostatic pathways. However, this …

Background and Aims Despite the significant medical and economic consequences of
coexisting alcohol use disorder (AUD) in patients with cirrhosis, little is known about AUD …

Patients with liver disease frequently acquire a complex disorder of hemostasis secondary to
their disease. Routine laboratory tests such as the prothrombin time and the platelet count …

Patients with acute and chronic liver disease frequently acquire unique changes in
haemodynamic and haemostatic pathways that may result in life-threatening bleeding and …

Disturbances of coagulation and hemostasis are common in patients with liver cirrhosis. The
typical laboratory pattern mimics disseminated intravascular coagulation (DIC). The aim of …

A “leaky gut” may be the cutting edge for the passage of toxins, antigens or bacteria into the
body, and may play a pathogenic role in advanced liver cirrhosis and its complications …

The liver plays a central role in the clotting process, and acute and chronic liver diseases are
invariably associated with coagulation disorders due to multiple causes: decreased …

Bacterial infections in cirrhotic patients are common. There is a predisposition to intestinal
bacterial overgrowth, intestinal dysmotility, and increased intestinal permeability, all leading …

Background & Aims: The bleeding tendency of patients suffering from cirrhosis is in part
ascribed to accelerated fibrinolysis. In this study, the role of the recently discovered inhibitor …